Jason Lilly compensation by year
NEOGEN Summary Compensation Table · all 7 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|
| Salary | $177,000 | $180,000 | $195,500 | $190,843 | $234,734 | $274,685 | $301,000 |
| Bonus | $50,000 | $55,000 | $58,500 | $42,000 | $99,932 | $191,388 | $132,500 |
| Stock awards | $0 | $0 | $0 | $0 | $200,461 | $385,019 | $188,004 |
| Option awards | $473,100 | $588,900 | $445,653 | $513,303 | $211,033 | $352,225 | $188,004 |
| Non-equity incentive | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $9,137 | $9,768 | $8,631 | $7,923 | $5,586 | $10,919 | $13,298 |
| Total | $709,237 | $833,668 | $708,284 | $754,069 | $751,746 | $1,214,236 | $822,806 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NEOGEN CORP DEF 14A filed September 18, 2023, accession 0000950170-23-048478, and prior-year filings. Open the filing on EDGAR.
How this page was built: the NEOGEN CORP filed document, accession 0000950170-23-048478. Every figure is read from that document and cited to the page and table it appears in. Filed September 18, 2023.
Equity holdings
unvested awards at FY2023 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 4,603 | $80,506 | — |
| RSU | 3,522 | $61,600 | — |
| Option | 12,000 | — | $31.35 |
| Option | 26,400 | — | $31.95 |
Per the Outstanding Equity Awards at Fiscal Year-End table in NEOGEN CORP's FY2023 proxy; value at the fiscal year-end close, as the company printed it.
NEOGEN’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| John Adent | President & Chief Executive Officer | $5,325,174 |
| David Naemura | Chief Financial Officer | $1,979,143 |
| Douglas Jones | Chief Operating Officer | $1,942,212 |
| Amy Rocklin | Chief Legal & Compliance Officer | $1,464,216 |
| Jason Lilly · this page | Vice President, Americas & Australia/New Zealand | $822,806 |
| Steven Quinlan | Vice President, Finance | $431,385 |
The full NEOGEN compensation record
free company briefThis page is one person within NEOGEN's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the NEOGEN proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NEOGEN's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.